Evidence map›Paper›PMID 29193853›Full record

ReviewProteomics. Clinical applications2018

Malaria in India: The Need for New Targets for Diagnosis and Detection of Plasmodium vivax.

Swati Patankar, Shobhona Sharma, Pradipsinh K Rathod, Manoj T Duraisingh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Proteomics. Clinical applications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Swati PatankarDepartment of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai, India.ORCID 0000-0001-7633-657X
Shobhona SharmaDepartment of Biological Sciences, Tata Institute of Fundamental Research, Mumbai, India.
Pradipsinh K RathodDepartment of Chemistry, University of Washington, Seattle, WA, USA.
Manoj T DuraisinghDepartment of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University · USTata Institute of Fundamental Research · INUniversity of Washington · US

Funding

Shared TechnologyU19AI089688 · NIAID · UNIVERSITY OF WASHINGTON · PI RATHOD, PRADIPSINH K. · 2010 to 2023
$22.4M
NIAID NIH HHS U19 AI089688
6 · The paper itself

Abstract

Plasmodium vivax is a protozoan parasite that is one of the causative agents of human malaria. Due to several occult features of its life cycle, P. vivax threatens to be a problem for the recent efforts toward elimination of malaria globally. With an emphasis on malaria elimination goals, the authors summarize the major gaps in P. vivax diagnosis and describe how proteomics technologies have begun to contribute toward the discovery of antigens that could be used for various technology platforms and applications. The authors suggest areas where, in the future, proteomics technologies could fill in gaps in P. vivax diagnosis that have proved difficult. The discovery of new parasite antigens, host responses, and immune signatures using proteomics technologies will be a key part of the global malaria elimination efforts.

Indexed as

HumansIndiaMalaria, VivaxPlasmodium vivaxProteomeProteomicsProtozoan ProteinsProteomeProtozoan Proteinseliminationmalariaproteomicsvivax

Identifiers

PMID29193853
PMCPMC5975085
OpenAlexW2768103041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.